Related Articles
Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas
Molecular and immunological aspects of p53 and p53-autoantibodies in head and neck squamous cell carcinoma
P53 EXPRESSION IN ESOPHAGEAL DYSPLASIA - A POSSIBLE BIOMARKER FOR CARCINOGENESIS OF ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
Mutant p53 protein in serum could be used as a molecular marker in human breast cancer
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma